RAPP
Rapport Therapeutics, Inc.
34.10$
-17.7%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.04 | 0.00 | 0.00 | 0.00 | 0.00 | 0.42 | 0.00 | 0.42 | |
| 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | – | – | |
| 0.00 | 0.00 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | 0.42 | – | – | |
| 0.40 | 0.65 | 0.64 | 0.78 | 0.81 | 0.89 | 1.01 | 0.64 | 0.59 | 0.64 | 0.69 | 1.08 | 2.88 | |
| 0.10 | 0.17 | 0.24 | 0.25 | 0.32 | 0.33 | 0.39 | 0.19 | 0.20 | 0.18 | 0.24 | 0.20 | 0.78 | |
| 0.50 | 0.82 | 0.88 | 1.03 | 1.13 | 1.22 | 1.41 | 0.83 | 0.79 | 0.82 | 0.94 | 1.28 | 3.66 | |
| -0.50 | -0.82 | -0.88 | -1.03 | -1.13 | -1.22 | -1.41 | -0.83 | -0.79 | -0.82 | -0.51 | -1.28 | -3.23 | |
| -0.46 | -0.75 | -1.17 | -0.90 | -0.91 | -1.04 | -1.25 | -0.75 | -0.71 | -0.72 | -0.42 | -1.19 | -2.89 | |
| 0.00 | 0.00 | – | – | – | – | – | – | – | – | – | – | – | |
| -0.46 | -0.75 | -1.17 | -0.90 | -0.91 | -1.04 | -1.25 | -0.75 | -0.71 | -0.72 | -0.42 | -1.19 | -2.89 | |
| -0.50 | -0.74 | -0.87 | -1.02 | -1.12 | -1.21 | -1.39 | -0.83 | -0.78 | -0.81 | -0.51 | -1.18 | -3.12 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.